Report cover image

Digital Health For Cardiovascular Market, By Component, By End-use, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Published Aug 04, 2025
Length 311 Pages
SKU # ANVM20791165

Description

REPORT HIGHLIGHT

Digital Health For Cardiovascular Market size was valued at US$ 42,624.29 Million in 2024, expanding at a CAGR of 22.50% from 2025 to 2032.
The Digital Health for Cardiovascular Market is a subset of healthcare that employs digital technologies such as mobile health apps, wearable devices, telemedicine, remote monitoring tools, artificial intelligence (AI), and cloud-based platforms to prevent, diagnose, monitor, and manage cardiovascular diseases. This market includes solutions that enable real-time data collection, remote patient engagement, and personalized cardiovascular care in order to improve patient outcomes, enhance clinical decision-making, and lower healthcare costs. It includes a wide range of products and services designed to treat conditions such as hypertension, arrhythmias, heart failure, and coronary artery disease using technology-driven interventions.
Digital Health For Cardiovascular Market- Market Dynamics

Surge In Cardiovascular Diseases Fuels Growth of Digital Health For Cardiovascular Market
The rising global prevalence of cardiovascular disease is expected to drive the growth of the Digital Health For Cardiovascular Market in the coming years. Cardiovascular diseases (CVDs) are conditions affecting the heart and blood vessels. It is a common term for diseases that harm the heart or blood vessels. Cardiovascular digital solutions help to promote patient autonomy by allowing patients to self-monitor health activities that reduce disease risk factors and encourage adherence to these lifestyle changes. The use of these solutions reduced the morbidity and mortality from cardiovascular diseases. As a result, the rise in cardiovascular disease cases drives up demand for cardiovascular digital solutions. For instance, in March 2024, according to data published by the Office for Health Improvement and Disparities, a UK-based government department, there were just over 1,862,500 people (3%) with a GP diagnosis of coronary heart disease in England. As a result, the global prevalence of cardiovascular disease is driving the Digital Health For Cardiovascular Market.
Digital Health For Cardiovascular Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.50% over the forecast period (2025-2032)
Based on Component segmentation, in 2025, the services segment will have the largest market share.
The provider segment held a significant market share in the end-use segment.
On the basis of region, North America generated the most revenue in 2025.
Digital Health For Cardiovascular Market- Segmentation Analysis:

The Global Digital Health For Cardiovascular Market is segmented on the basis of Component, End-use, and Region.
The market is divided into three categories based on Component: Software, Services, and Hardware. In 2025, the services segment will account for the largest market share. Market service providers offer their solutions in both integrated packages and individual products. The growing demand for advanced software and platforms, such as Electronic Medical Records (EMRs) and Electronic Health Records (EHRs), is propelling segment expansion. For instance, in January 2024, Medtronic and Cardiac Design Labs collaborated to introduce Padma Rhythms, a new Electronic Loop Recorder (ELR) patch. Furthermore, the growing need for telehealth applications to monitor cardiovascular health in real time, rapid advancements in digital infrastructure, rising internet and smartphone penetration, and rapid development of hardware and software components are all expected to drive segment growth.
The market is divided into four categories based on End-use: Patients, Payers, Providers, and Others. The provider segment accounted for a significant market share in the end-use segment, owing to the rapid adoption of innovative technologies such as digital therapeutics and telemedicine. Healthcare providers are rapidly adopting digital solutions to deliver personalized treatment plans, remote consultations, and evidence-based therapies that go beyond traditional care. By incorporating digital tools, providers can provide more personalized and accessible care, which ultimately leads to better patient outcomes. These factors contribute to the growth of digital health in the cardiovascular market, improving patient outcomes and healthcare efficiency.
Digital Health For Cardiovascular Market- Geographical Insights

North America will dominate the overall digital health for the cardiovascular industry in 2025, owing to increased healthcare IT expenditure to support digital infrastructure, technological advancements, and supportive government initiatives. For instance, in May 2022, the American College of Cardiology published principles guidelines to support digital health initiatives and announce the most recent scientific discoveries. Furthermore, the population in North America is increasingly adopting wearable devices for health management in conjunction with telemedicine platforms. These integrated systems play a critical role in improving patient outcomes and overall community health by allowing for early intervention.
Asia Pacific is expected to have the fastest CAGR over the forecast period. The regional market is expected to grow due to increased mHealth platform adoption and healthcare expenditure in the region. Furthermore, the Asia Pacific region's industry growth is expected to be driven by technological advancements in the field as government spending on healthcare increases. The growing involvement of key market players, as well as the emergence of niche entrepreneurial ventures in Asia Pacific, have boosted regional adoption of digital apps and platforms.
Digital Health For Cardiovascular Market- Competitive Landscape:

The digital health for cardiovascular market is highly competitive and rapidly evolving, with key players using advanced technologies such as AI, IoT, wearable devices, and cloud-based platforms to improve cardiovascular disease management. Apple, Inc., Ultrasonics Limited, Orange Business, Siemens Healthineers AG, and Epic Systems Corporation are pioneers in remote patient monitoring, smart diagnostics, and telecardiology solutions, driving market innovation. Startups and health-tech companies such as iRhythm Technologies and AliveCor are also gaining traction for providing AI-powered ECG monitoring and arrhythmia detection. Strategic collaborations, product launches, and regulatory approvals are driving up competition, while increased investments in digital therapeutics and personalised care are reshaping the industry landscape.

Recent Developments:

In March 2024, Wellysis, a Samsung subsidiary, has collaborated with Artella Solutions (ARTELLA) to launch its remote cardiac monitoring service in the United States. This collaboration aims to provide the FDA-cleared S-Patch electrocardiogram monitoring solution from ARTELLA in ten states.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Apple, Inc.
Ultrasonics Limited
Orange Business
Siemens Healthineers AG
Epic Systems Corporation
NXGN Management, LLC.
GE HealthCare
Viz.ai, Inc.
CardiAI
Ultrasonics Limited
Cardiologs
UltraSight
HeartVista Inc. (Vista.ai)
RSIP Vision
Cleerly, Inc.
Others

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

Software
Services
Hardware

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY END-USE- MARKET ANALYSIS, 2019 - 2032

Patients
Payers
Providers
Others

GLOBAL DIGITAL HEALTH FOR CARDIOVASCULAR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Table of Contents

311 Pages
1. Viral Vector Contract Development Manufacturing Organizations Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Vector Type
2.1.2. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Workflow Stage
2.1.3. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Scale
2.1.4. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Application
2.1.5. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Country
2.1.6. Viral Vector Contract Development Manufacturing Organizations Market Snippet by Region
2.2. Competitive Insights
3. Viral Vector Contract Development Manufacturing Organizations Key Market Trends
3.1. Viral Vector Contract Development Manufacturing Organizations Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Viral Vector Contract Development Manufacturing Organizations Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Viral Vector Contract Development Manufacturing Organizations Market Opportunities
3.4. Viral Vector Contract Development Manufacturing Organizations Market Future Trends
4. Viral Vector Contract Development Manufacturing Organizations Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Viral Vector Contract Development Manufacturing Organizations Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Viral Vector Contract Development Manufacturing Organizations Market Landscape
6.1. Viral Vector Contract Development Manufacturing Organizations Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Viral Vector Contract Development Manufacturing Organizations Market – By Vector Type
7.1. Overview
7.1.1. Segment Share Analysis, By Vector Type, 2024 & 2032 (%)
7.1.2. Adenovirus
7.1.3. Lentivirus
7.1.4. Adeno-associated Virus
7.1.5. Retrovirus
7.1.6. Herpes Simplex Virus
7.1.7. Hybrid/Chimeric Vectors
8. Viral Vector Contract Development Manufacturing Organizations Market – By Workflow Stage
8.1. Overview
8.1.1. Segment Share Analysis, By Workflow Stage, 2024 & 2032 (%)
8.1.2. Upstream Processing
8.1.2.1. Cell culture (HEK293, Sf9)
8.1.2.2. Transfection/infection protocols
8.1.3. Downstream Processing
8.1.3.1. Filtration & Chromatography
8.1.3.2. Ultracentrifugation
8.1.3.3. Final Product Formulation
9. Viral Vector Contract Development Manufacturing Organizations Market – By Scale
9.1. Overview
9.1.1. Segment Share Analysis, By Scale, 2024 & 2032 (%)
9.1.2. Preclinical (R&D batches)
9.1.3. Clinical (Phase I–III)
9.1.4. Commercial (Market-ready supply)
10. Viral Vector Contract Development Manufacturing Organizations Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Gene Therapy
10.1.3. Cancer Immunotherapy
10.1.4. Infectious Disease Vaccines
10.1.5. Rare Disease Treatment
11. Viral Vector Contract Development Manufacturing Organizations Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Viral Vector Contract Development Manufacturing Organizations Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Vector Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Workflow Stage, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Scale, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Viral Vector Contract Development Manufacturing Organizations Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. AGC Biologics
12.2.2. Aldevron
12.2.3. Batavia Biosciences
12.2.4. BioReliance (Merck KGaA)
12.2.5. Catalent
12.2.6. Charles River Laboratories
12.2.7. Cobra Biologics (Charles River)
12.2.8. FUJIFILM Diosynth Biotechnologies
12.2.9. Genezen
12.2.10. iBET
12.2.11. Kaneka Eurogentec
12.2.12. Lonza
12.2.13. Novasep
12.2.14. Oxford Biomedica
12.2.15. REGENXBIO (CDMO Services arm)
12.2.16. Thermo Fisher Scientific (Patheon)
12.2.17. Vigene Biosciences (Charles River)
12.2.18. VIVEbiotech
12.2.19. WuXi Advanced Therapies
12.2.20. Yposkesi
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.